|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | sTREM-1 is a specific biomarker of TREM-1 pathway activation显示文摘TREM-1(triggering receptor expressed on myeloid cells-1)is a transmembrane receptor expressed by innate immune cells,including endothelial cells and platelets.TREM-1 is a crucial mediator of septic shock that acts by synergizing with Toll-like receptors(TLRs)to amplify the inflammatory responses to pathogens,thus promoting sepsis-induced immune dysregulation and organ dysfunction[1,2,3]. | Lucie Jolly Kévin Carrasco Margarita Salcedo-Magguilli Jean-Jacques Garaud Simon Lambden Tom van der Poll Alexandre Mebazaa Pierre-François Laterre Sebastien Gibot Amir Boufenzer Marc Derive | 2021 | Cellular & Molecular Immunology2021，18，8： | 8 |
| 2 | Value of pelvic embolization in the management of severe postpartum hemorrhage due to placenta accreta, increta or percreta显示文摘 | Philippe Soyer Olivier Morel Yann Fargeaudou Marc Sirol Fabrice Staub Mourad Boudiaf Henri Dahan Alexandre Mebazaa Emmanuel Barranger Olivier le Dref | 2010 | European Journal of Radiology2010，，3： | 2 |
| 3 | Year in review in Intensive Care Medicine 2009: I. Pneumonia and infections, sepsis, outcome, acute renal failure and acid base, nutrition and glycaemic control显示文摘 | Massimo Antonelli Elie Azoulay Marc Bonten Jean Chastre Giuseppe Citerio Giorgio Conti Daniel Backer Fran?ois Lemaire Herwig Gerlach Goran Hedenstierna Michael Joannidis Duncan Macrae Jordi Mancebo Salvatore M. Maggiore Alexandre Mebazaa Jean-Charles Prei | 2010 | Intensive Care Medicine2010，，2： | 1 |
| 4 | Cardio-Renal Syndrome Type 2: Epidemiology, Pathophysiology, and Treatment显示文摘 | Preeti Jois Alexandre Mebazaa | 2012 | Seminars in Nephrology2012，，1： | 1 |
| 5 | Value of pelvic embolization in the management of severe postpartum hemorrhage due to placenta accreta, increta or percreta显示文摘 | Philippe Soyer Olivier Morel Yann Fargeaudou Marc Sirol Fabrice Staub Mourad Boudiaf Henri Dahan Alexandre Mebazaa Emmanuel Barranger Olivier le Dref | 2010 | European Journal of Radiology2010，，3： | 1 |
| 6 | Use of B-type natriuretic peptide in critically ill patients显示文摘 | Romain Pirracchio Reda Salem Alexandre Mebazaa | 2009 | Biomarkers Med2009，，5： | 1 |
| 7 | Persistent postpartum haemorrhage after failed arterial ligation: value of pelvic embolisation显示文摘 | Yann Fargeaudou Olivier Morel Philippe Soyer Etienne Gayat Marc Sirol Mourad Boudiaf Henri Dahan Emmanuel Barranger Alexandre Mebazaa Olivier Dref | 2010 | European Radiology2010，，7： | 1 |
| 8 | Current management and future directions for the treatment of patients hospitalized for heart failure with low blood pressure显示文摘 | Mihai Gheorghiade Muthiah Vaduganathan Andrew Ambrosy Michael B?hm Umberto Campia John G. F. Cleland Francesco Fedele Gregg C. Fonarow Aldo P. Maggioni Alexandre Mebazaa Mandeep Mehra Marco Metra Savina Nodari Peter S. Pang Piotr Ponikowski Hani N. Sabbah | 2013 | Heart Failure Reviews2013，，2： | 1 |
| 9 | Diagnosis and treatment of iron deficiency in patients with heart failure: Expert position paper from French cardiologists显示文摘 | Alain Cohen-Solal Christophe Leclercq Alexandre Mebazaa Pascal De Groote Thibaud Damy Richard Isnard Michel Galinier | 2014 | Archives of Cardiovascular Diseases2014，，10： | 1 |
| 10 | Heart‘omicsin’AGEing (HOMAGE):design,research objectives and characteristics of the common database显示文摘Heart failure is common in older people and its prevalence is increasing.The Heart 'omics' in AGEing(HOMAGE) project aims to provide a biomarker approach that will improve the early diagnosis of heart failure.A large clinical database,based on(1) prospective population studies or(2) cross-sectional,prospective studies or randomized controlled trials(RCTs) of patients at risk for or with overt cardiovascular disease will be constructed to determine most promising 'omics'-based biomarkers to identify the risk of developing heart failure and/or comorbidities.Population studies,patient cohorts and RCTs are eligible for inclusion in the common database,if they received ethical approval to obtain and share data and have baseline information on cardiovascular risk factors.Currently,the HOMAGE database includes 43,065 subjects,from 20 studies in eight European countries,including healthy subjects from three population studies in France,Belgium and Italy(n = 7,124),patients with heart failure(n = 4,312) from four cohorts in the UK,Spain and Switzerland and patients at high risk for cardiovascular disease(n = 31,629) in 13 cohorts.It is anticipated that more partners will join the consortium and enlarge the pooled data.This large merged database will be a useful resource with which to identify candidate biomarkers that play a role in the mechanism underlying the onset and progression of heart failure. | Lotte Jacobs Lutgarde Thijs Yu Jin Faiez Zannad Alexandre Mebazaa Philippe Rouet Florence Pinet Christophe Bauters Burkert Pieske Andreas Tomaschitz Mamas Mamas Javier Diez Kenneth McDonald John G F Cleland Hans-Peter Brunner-La Rocca Stephane Heymans Roberto Latini Serge Masson Peter Sever Christian Delles Stuart Pocock Timothy Collier Tatiana Kuznetsova Jan A Staessen | 2014 | The Journal of Biomedical Research2014，28，5： | 1 |
| 11 | Microvascular Effects of Heart Rate Control With Esmolol in Patients With Septic Shock: A Pilot Study*显示文摘 | Andrea Morelli Abele Donati Christian Ertmer Sebastian Rehberg Tim Kampmeier Alessandra Orecchioni Annalia D’Egidio Valeria Cecchini Giovanni Landoni Paolo Pietropaoli Martin Westphal Mario Venditti Alexandre Mebazaa Mervyn Singer | 2013 | Critical Care Medicine2013，，9： | 1 |
| 12 | Prognostic markers of acute decompensated heart failure: The emerging roles of cardiac biomarkers and prognostic scores显示文摘 | Alain Cohen-Solal Said Laribi Shiro Ishihara Giuseppe Vergaro Mathilde Baudet Damien Logeart Alexandre Mebazaa Etienne Gayat Nicolas Vodovar Domingo A. Pascual-Figal Marie-France Seronde | 2014 | Archives of Cardiovascular Diseases2014，，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员